デフォルト表紙
市場調査レポート
商品コード
1419409

自己投与非経口薬の世界市場に関する洞察、2030年までの予測

Global Self-administered Parenteral Market Insights, Forecast to 2030

出版日: | 発行: QYResearch | ページ情報: 英文 114 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.54円
自己投与非経口薬の世界市場に関する洞察、2030年までの予測
出版日: 2024年02月01日
発行: QYResearch
ページ情報: 英文 114 Pages
納期: 2~3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、自己投与非経口薬 (Self-administered Parenteral) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • 自己投与非経口薬の製品概要
  • 市場:タイプ別
    • 世界の自己投与非経口薬の市場規模成長率:タイプ別, 2019 VS 2023 VS 2030
    • Pre-filled Syringes
    • Autoinjectors
    • Pen Injectors
    • Others
  • 市場:用途別
    • 世界の自己投与非経口薬の市場規模成長率:用途別, 2019 VS 2023 VS 2030
    • Pharmacy
    • Online Sales
    • Other
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 レポート概要

  • 世界の自己投与非経口薬 売上予測・予想 2019-2030
  • 世界の自己投与非経口薬の収益:地域別
    • 世界の自己投与非経口薬の収益:地域別: 2019 VS 2023 VS 2030
    • 世界の自己投与非経口薬の収益:地域別 (2019-2024)
    • 世界の自己投与非経口薬の収益:地域別 (2025-2030)
    • 世界の自己投与非経口薬の収益市場シェア 地域別 (2019-2030)
  • 世界の自己投与非経口薬 売上予測・予想 2019-2030
  • 世界の自己投与非経口薬の販売:地域別
    • 世界の自己投与非経口薬の販売:地域別: 2019 VS 2023 VS 2030
    • 世界の自己投与非経口薬の販売:地域別 (2019-2024)
    • 世界の自己投与非経口薬の販売:地域別 (2025-2030)
    • 世界の自己投与非経口薬の販売市場シェア 地域別 (2019-2030)
  • 米国・カナダ
  • 欧州
  • 中国
  • アジア(中国を除く)
  • 中東, アフリカ ・ラテンアメリカ

第3章 競合:企業別

  • 世界の自己投与非経口薬の販売:企業別
    • 世界の自己投与非経口薬の販売:企業別 (2019-2024)
    • 世界の自己投与非経口薬の販売市場シェア:企業別 (2019-2024)
    • 世界の上位10・上位5企業: 自己投与非経口薬 in 2023
  • 世界の自己投与非経口薬の収益:企業別
    • 世界の自己投与非経口薬の収益:企業別 (2019-2024)
    • 世界の自己投与非経口薬の収益市場シェア:企業別 (2019-2024)
    • 世界の上位10・上位5企業: 自己投与非経口薬の収益 2023
  • 世界の主要企業 自己投与非経口薬, 業界ランキング, 2022 VS 2023 VS 2024
  • 世界の自己投与非経口薬の販売価格:企業別
  • 競合情勢の分析
    • 企業の市場集中度 (CR5 and HHI)
    • 世界の自己投与非経口薬の市場シェア:企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要メーカー 自己投与非経口薬, 製造拠点分布と本社
  • 世界の主要メーカー 自己投与非経口薬, 提供製品と用途
  • 世界の主要メーカー 自己投与非経口薬, 業界参入時期
  • M&A, 拡張計画

第4章 市場規模:タイプ別

  • 世界の自己投与非経口薬の販売:タイプ別
    • 世界の自己投与非経口薬の販売実績:タイプ別 (2019-2024)
    • 世界の自己投与非経口薬の販売予測:タイプ別 (2025-2030)
    • 世界の自己投与非経口薬の販売市場シェア:タイプ別 (2019-2030)
  • 世界の自己投与非経口薬 収益:タイプ別
    • 世界の自己投与非経口薬の収益実績:タイプ別 (2019-2024)
    • 世界の自己投与非経口薬の収益予測:タイプ別 (2025-2030)
    • 世界の自己投与非経口薬の収益市場シェア:タイプ別 (2019-2030)
  • 世界の自己投与非経口薬の価格:タイプ別
    • 世界の自己投与非経口薬の価格:タイプ別 (2019-2024)
    • 世界の自己投与非経口薬の価格予測:タイプ別 (2025-2030)

第5章 市場規模:用途別

  • 世界の自己投与非経口薬の販売:用途別
    • 世界の自己投与非経口薬の販売実績:用途別 (2019-2024)
    • 世界の自己投与非経口薬の販売予測:用途別 (2025-2030)
    • 世界の自己投与非経口薬の販売市場シェア:用途別 (2019-2030)
  • 世界の自己投与非経口薬の収益:用途別
    • 世界の自己投与非経口薬の収益実績:用途別 (2019-2024)
    • 世界の自己投与非経口薬の収益予測:用途別 (2025-2030)
    • 世界の自己投与非経口薬の収益市場シェア:用途別 (2019-2030)
  • 世界の自己投与非経口薬の価格:用途別
    • 世界の自己投与非経口薬の価格:用途別 (2019-2024)
    • 世界の自己投与非経口薬の価格予測:用途別 (2025-2030)

第6章 米国・カナダ

  • 米国・カナダ 自己投与非経口薬 市場規模:タイプ別
    • 米国・カナダ 自己投与非経口薬の販売:タイプ別 (2019-2030)
    • 米国・カナダ 自己投与非経口薬 収益:タイプ別 (2019-2030)
  • 米国・カナダ 自己投与非経口薬 市場規模:用途別
    • 米国・カナダ 自己投与非経口薬の販売:用途別 (2019-2030)
    • 米国・カナダ 自己投与非経口薬の収益:用途別 (2019-2030)
  • 米国・カナダ 自己投与非経口薬 市場規模:国別
    • 米国・カナダ 自己投与非経口薬の収益:国別: 2019 VS 2023 VS 2030
    • 米国・カナダ 自己投与非経口薬の販売:国別 (2019-2030)
    • 米国・カナダ 自己投与非経口薬の収益:国別 (2019-2030)
    • US
    • カナダ

第7章 欧州

  • 欧州の自己投与非経口薬 市場規模:タイプ別
    • 欧州の自己投与非経口薬の販売:タイプ別 (2019-2030)
    • 欧州の自己投与非経口薬 収益:タイプ別 (2019-2030)
  • 欧州の自己投与非経口薬 市場規模:用途別
    • 欧州の自己投与非経口薬の販売:用途別 (2019-2030)
    • 欧州の自己投与非経口薬の収益:用途別 (2019-2030)
  • 欧州の自己投与非経口薬 市場規模:国別
    • 欧州の自己投与非経口薬の収益:国別: 2019 VS 2023 VS 2030
    • 欧州の自己投与非経口薬の販売:国別 (2019-2030)
    • 欧州の自己投与非経口薬の収益:国別 (2019-2030)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • オランダ

第8章 中国

  • 中国の自己投与非経口薬 市場規模
    • 中国の自己投与非経口薬 売上 (2019-2030)
    • 中国の自己投与非経口薬 収益 (2019-2030)
  • 中国の自己投与非経口薬 市場規模:用途別
    • 中国の自己投与非経口薬の販売:用途別 (2019-2030)
    • 中国の自己投与非経口薬の収益:用途別 (2019-2030)

第9章 アジア(中国を除く)

  • アジア地域 自己投与非経口薬 市場規模:タイプ別
    • アジア地域 自己投与非経口薬の販売:タイプ別 (2019-2030)
    • アジア地域 自己投与非経口薬 収益:タイプ別 (2019-2030)
  • アジア地域 自己投与非経口薬 市場規模:用途別
    • アジア地域 自己投与非経口薬の販売:用途別 (2019-2030)
    • アジア地域 自己投与非経口薬の収益:用途別 (2019-2030)
  • アジア地域 自己投与非経口薬の販売:地域別
    • アジア地域 自己投与非経口薬の収益:地域別: 2019 VS 2023 VS 2030
    • アジア地域 自己投与非経口薬の収益:地域別 (2019-2030)
    • アジア地域 自己投与非経口薬の販売:地域別 (2019-2030)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド

第10章 中東, アフリカ ・ラテンアメリカ

  • 中東, アフリカ ・ラテンアメリカの自己投与非経口薬 市場規模:タイプ別
    • 中東, アフリカ ・ラテンアメリカの自己投与非経口薬の販売:タイプ別 (2019-2030)
    • 中東, アフリカ ・ラテンアメリカの自己投与非経口薬 収益:タイプ別 (2019-2030)
  • 中東, アフリカ ・ラテンアメリカの自己投与非経口薬 市場規模:用途別
    • 中東, アフリカ ・ラテンアメリカの自己投与非経口薬の販売:用途別 (2019-2030)
    • 中東, アフリカ ・ラテンアメリカの自己投与非経口薬の収益:用途別 (2019-2030)
  • 中東, アフリカ ・ラテンアメリカの自己投与非経口薬の販売:国別
    • 中東, アフリカ ・ラテンアメリカの自己投与非経口薬の収益:国別: 2019 VS 2023 VS 2030
    • 中東, アフリカ ・ラテンアメリカの自己投与非経口薬の収益:国別 (2019-2030)
    • 中東, アフリカ ・ラテンアメリカの自己投与非経口薬の販売:国別 (2019-2030)
    • ブラジル
    • メキシコ
    • トルコ
    • イスラエル
    • 湾岸協力理事会諸国

第11章 企業プロファイル

  • Becton, Dickinson and Company
  • scPharmaceuticals
  • Harro Hofliger
  • Owen Mumford
  • Haselmeier
  • Stevanato Group
  • Ypsomed AG
  • Solteam Group
  • AstraZeneca
  • Enable lnjections
  • CCBio
  • Phillips-Medisize Corporation
  • Sorrel Medical
  • Krontec Healthcare
  • Subcuject Aps
  • Ascendia Pharmaceuticals
  • West Pharmaceutical Services, Inc.

第12章 業界チェーンと販売チャネルの分析

  • 自己投与非経口薬 業界チェーン分析
  • 自己投与非経口薬 主要原材料
    • 主要原材料
    • 原材料の主要サプライヤー
  • 自己投与非経口薬 生産形態とプロセス
  • 自己投与非経口薬 販売およびマーケティング
    • 自己投与非経口薬 販売チャネルs
    • 自己投与非経口薬 卸業者
  • 自己投与非経口薬 顧客

第13章 市場動向

  • 自己投与非経口薬 業界動向
  • 自己投与非経口薬 市場の促進要因
  • 自己投与非経口薬 市場の課題
  • 自己投与非経口薬 市場の抑制要因

第14章 主な調査結果 世界の自己投与非経口薬の主な市場調査結果

第15章 付録

図表

List of Tables

  • Table 1. Global Self-administered Parenteral Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
  • Table 2. Major Manufacturers of Pre-filled Syringes
  • Table 3. Major Manufacturers of Autoinjectors
  • Table 4. Major Manufacturers of Pen Injectors
  • Table 5. Major Manufacturers of Others
  • Table 6. Global Self-administered Parenteral Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
  • Table 7. Global Self-administered Parenteral Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 8. Global Self-administered Parenteral Revenue by Region (2019-2024) & (US$ Million)
  • Table 9. Global Self-administered Parenteral Revenue by Region (2025-2030) & (US$ Million)
  • Table 10. Global Self-administered Parenteral Revenue Market Share by Region (2019-2024)
  • Table 11. Global Self-administered Parenteral Revenue Market Share by Region (2025-2030)
  • Table 12. Global Self-administered Parenteral Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 13. Global Self-administered Parenteral Sales by Region (2019-2024) & (K Units)
  • Table 14. Global Self-administered Parenteral Sales by Region (2025-2030) & (K Units)
  • Table 15. Global Self-administered Parenteral Sales Market Share by Region (2019-2024)
  • Table 16. Global Self-administered Parenteral Sales Market Share by Region (2025-2030)
  • Table 17. Global Self-administered Parenteral Sales by Manufacturers (2019-2024) & (K Units)
  • Table 18. Global Self-administered Parenteral Sales Share by Manufacturers (2019-2024)
  • Table 19. Global Self-administered Parenteral Revenue by Manufacturers (2019-2024) & (US$ Million)
  • Table 20. Global Self-administered Parenteral Revenue Share by Manufacturers (2019-2024)
  • Table 21. Global Key Players of Self-administered Parenteral, Industry Ranking, 2022 VS 2023 VS 2024
  • Table 22. Self-administered Parenteral Price by Manufacturers 2019-2024 (US$/Unit)
  • Table 23. Global Self-administered Parenteral Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 24. Global Self-administered Parenteral by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Self-administered Parenteral as of 2023)
  • Table 25. Global Key Manufacturers of Self-administered Parenteral, Manufacturing Base Distribution and Headquarters
  • Table 26. Global Key Manufacturers of Self-administered Parenteral, Product Offered and Application
  • Table 27. Global Key Manufacturers of Self-administered Parenteral, Date of Enter into This Industry
  • Table 28. Mergers & Acquisitions, Expansion Plans
  • Table 29. Global Self-administered Parenteral Sales by Type (2019-2024) & (K Units)
  • Table 30. Global Self-administered Parenteral Sales by Type (2025-2030) & (K Units)
  • Table 31. Global Self-administered Parenteral Sales Share by Type (2019-2024)
  • Table 32. Global Self-administered Parenteral Sales Share by Type (2025-2030)
  • Table 33. Global Self-administered Parenteral Revenue by Type (2019-2024) & (US$ Million)
  • Table 34. Global Self-administered Parenteral Revenue by Type (2025-2030) & (US$ Million)
  • Table 35. Global Self-administered Parenteral Revenue Share by Type (2019-2024)
  • Table 36. Global Self-administered Parenteral Revenue Share by Type (2025-2030)
  • Table 37. Self-administered Parenteral Price by Type (2019-2024) & (US$/Unit)
  • Table 38. Global Self-administered Parenteral Price Forecast by Type (2025-2030) & (US$/Unit)
  • Table 39. Global Self-administered Parenteral Sales by Application (2019-2024) & (K Units)
  • Table 40. Global Self-administered Parenteral Sales by Application (2025-2030) & (K Units)
  • Table 41. Global Self-administered Parenteral Sales Share by Application (2019-2024)
  • Table 42. Global Self-administered Parenteral Sales Share by Application (2025-2030)
  • Table 43. Global Self-administered Parenteral Revenue by Application (2019-2024) & (US$ Million)
  • Table 44. Global Self-administered Parenteral Revenue by Application (2025-2030) & (US$ Million)
  • Table 45. Global Self-administered Parenteral Revenue Share by Application (2019-2024)
  • Table 46. Global Self-administered Parenteral Revenue Share by Application (2025-2030)
  • Table 47. Self-administered Parenteral Price by Application (2019-2024) & (US$/Unit)
  • Table 48. Global Self-administered Parenteral Price Forecast by Application (2025-2030) & (US$/Unit)
  • Table 49. US & Canada Self-administered Parenteral Sales by Type (2019-2024) & (K Units)
  • Table 50. US & Canada Self-administered Parenteral Sales by Type (2025-2030) & (K Units)
  • Table 51. US & Canada Self-administered Parenteral Revenue by Type (2019-2024) & (US$ Million)
  • Table 52. US & Canada Self-administered Parenteral Revenue by Type (2025-2030) & (US$ Million)
  • Table 53. US & Canada Self-administered Parenteral Sales by Application (2019-2024) & (K Units)
  • Table 54. US & Canada Self-administered Parenteral Sales by Application (2025-2030) & (K Units)
  • Table 55. US & Canada Self-administered Parenteral Revenue by Application (2019-2024) & (US$ Million)
  • Table 56. US & Canada Self-administered Parenteral Revenue by Application (2025-2030) & (US$ Million)
  • Table 57. US & Canada Self-administered Parenteral Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 58. US & Canada Self-administered Parenteral Revenue by Country (2019-2024) & (US$ Million)
  • Table 59. US & Canada Self-administered Parenteral Revenue by Country (2025-2030) & (US$ Million)
  • Table 60. US & Canada Self-administered Parenteral Sales by Country (2019-2024) & (K Units)
  • Table 61. US & Canada Self-administered Parenteral Sales by Country (2025-2030) & (K Units)
  • Table 62. Europe Self-administered Parenteral Sales by Type (2019-2024) & (K Units)
  • Table 63. Europe Self-administered Parenteral Sales by Type (2025-2030) & (K Units)
  • Table 64. Europe Self-administered Parenteral Revenue by Type (2019-2024) & (US$ Million)
  • Table 65. Europe Self-administered Parenteral Revenue by Type (2025-2030) & (US$ Million)
  • Table 66. Europe Self-administered Parenteral Sales by Application (2019-2024) & (K Units)
  • Table 67. Europe Self-administered Parenteral Sales by Application (2025-2030) & (K Units)
  • Table 68. Europe Self-administered Parenteral Revenue by Application (2019-2024) & (US$ Million)
  • Table 69. Europe Self-administered Parenteral Revenue by Application (2025-2030) & (US$ Million)
  • Table 70. Europe Self-administered Parenteral Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 71. Europe Self-administered Parenteral Revenue by Country (2019-2024) & (US$ Million)
  • Table 72. Europe Self-administered Parenteral Revenue by Country (2025-2030) & (US$ Million)
  • Table 73. Europe Self-administered Parenteral Sales by Country (2019-2024) & (K Units)
  • Table 74. Europe Self-administered Parenteral Sales by Country (2025-2030) & (K Units)
  • Table 75. China Self-administered Parenteral Sales by Type (2019-2024) & (K Units)
  • Table 76. China Self-administered Parenteral Sales by Type (2025-2030) & (K Units)
  • Table 77. China Self-administered Parenteral Revenue by Type (2019-2024) & (US$ Million)
  • Table 78. China Self-administered Parenteral Revenue by Type (2025-2030) & (US$ Million)
  • Table 79. China Self-administered Parenteral Sales by Application (2019-2024) & (K Units)
  • Table 80. China Self-administered Parenteral Sales by Application (2025-2030) & (K Units)
  • Table 81. China Self-administered Parenteral Revenue by Application (2019-2024) & (US$ Million)
  • Table 82. China Self-administered Parenteral Revenue by Application (2025-2030) & (US$ Million)
  • Table 83. Asia Self-administered Parenteral Sales by Type (2019-2024) & (K Units)
  • Table 84. Asia Self-administered Parenteral Sales by Type (2025-2030) & (K Units)
  • Table 85. Asia Self-administered Parenteral Revenue by Type (2019-2024) & (US$ Million)
  • Table 86. Asia Self-administered Parenteral Revenue by Type (2025-2030) & (US$ Million)
  • Table 87. Asia Self-administered Parenteral Sales by Application (2019-2024) & (K Units)
  • Table 88. Asia Self-administered Parenteral Sales by Application (2025-2030) & (K Units)
  • Table 89. Asia Self-administered Parenteral Revenue by Application (2019-2024) & (US$ Million)
  • Table 90. Asia Self-administered Parenteral Revenue by Application (2025-2030) & (US$ Million)
  • Table 91. Asia Self-administered Parenteral Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 92. Asia Self-administered Parenteral Revenue by Region (2019-2024) & (US$ Million)
  • Table 93. Asia Self-administered Parenteral Revenue by Region (2025-2030) & (US$ Million)
  • Table 94. Asia Self-administered Parenteral Sales by Region (2019-2024) & (K Units)
  • Table 95. Asia Self-administered Parenteral Sales by Region (2025-2030) & (K Units)
  • Table 96. Middle East, Africa and Latin America Self-administered Parenteral Sales by Type (2019-2024) & (K Units)
  • Table 97. Middle East, Africa and Latin America Self-administered Parenteral Sales by Type (2025-2030) & (K Units)
  • Table 98. Middle East, Africa and Latin America Self-administered Parenteral Revenue by Type (2019-2024) & (US$ Million)
  • Table 99. Middle East, Africa and Latin America Self-administered Parenteral Revenue by Type (2025-2030) & (US$ Million)
  • Table 100. Middle East, Africa and Latin America Self-administered Parenteral Sales by Application (2019-2024) & (K Units)
  • Table 101. Middle East, Africa and Latin America Self-administered Parenteral Sales by Application (2025-2030) & (K Units)
  • Table 102. Middle East, Africa and Latin America Self-administered Parenteral Revenue by Application (2019-2024) & (US$ Million)
  • Table 103. Middle East, Africa and Latin America Self-administered Parenteral Revenue by Application (2025-2030) & (US$ Million)
  • Table 104. Middle East, Africa and Latin America Self-administered Parenteral Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 105. Middle East, Africa and Latin America Self-administered Parenteral Revenue by Country (2019-2024) & (US$ Million)
  • Table 106. Middle East, Africa and Latin America Self-administered Parenteral Revenue by Country (2025-2030) & (US$ Million)
  • Table 107. Middle East, Africa and Latin America Self-administered Parenteral Sales by Country (2019-2024) & (K Units)
  • Table 108. Middle East, Africa and Latin America Self-administered Parenteral Sales by Country (2025-2030) & (K Units)
  • Table 109. Becton, Dickinson and Company Company Information
  • Table 110. Becton, Dickinson and Company Description and Major Businesses
  • Table 111. Becton, Dickinson and Company Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 112. Becton, Dickinson and Company Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 113. Becton, Dickinson and Company Recent Developments
  • Table 114. scPharmaceuticals Company Information
  • Table 115. scPharmaceuticals Description and Major Businesses
  • Table 116. scPharmaceuticals Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 117. scPharmaceuticals Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 118. scPharmaceuticals Recent Developments
  • Table 119. Harro Hofliger Company Information
  • Table 120. Harro Hofliger Description and Major Businesses
  • Table 121. Harro Hofliger Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 122. Harro Hofliger Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 123. Harro Hofliger Recent Developments
  • Table 124. Owen Mumford Company Information
  • Table 125. Owen Mumford Description and Major Businesses
  • Table 126. Owen Mumford Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 127. Owen Mumford Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 128. Owen Mumford Recent Developments
  • Table 129. Haselmeier Company Information
  • Table 130. Haselmeier Description and Major Businesses
  • Table 131. Haselmeier Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 132. Haselmeier Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 133. Haselmeier Recent Developments
  • Table 134. Stevanato Group Company Information
  • Table 135. Stevanato Group Description and Major Businesses
  • Table 136. Stevanato Group Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 137. Stevanato Group Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 138. Stevanato Group Recent Developments
  • Table 139. Ypsomed AG Company Information
  • Table 140. Ypsomed AG Description and Major Businesses
  • Table 141. Ypsomed AG Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 142. Ypsomed AG Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 143. Ypsomed AG Recent Developments
  • Table 144. Solteam Group Company Information
  • Table 145. Solteam Group Description and Major Businesses
  • Table 146. Solteam Group Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 147. Solteam Group Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 148. Solteam Group Recent Developments
  • Table 149. AstraZeneca Company Information
  • Table 150. AstraZeneca Description and Major Businesses
  • Table 151. AstraZeneca Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 152. AstraZeneca Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 153. AstraZeneca Recent Developments
  • Table 154. Enable lnjections Company Information
  • Table 155. Enable lnjections Description and Major Businesses
  • Table 156. Enable lnjections Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 157. Enable lnjections Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 158. Enable lnjections Recent Developments
  • Table 159. CCBio Company Information
  • Table 160. CCBio Description and Major Businesses
  • Table 161. CCBio Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 162. CCBio Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 163. CCBio Recent Developments
  • Table 164. Phillips-Medisize Corporation Company Information
  • Table 165. Phillips-Medisize Corporation Description and Major Businesses
  • Table 166. Phillips-Medisize Corporation Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 167. Phillips-Medisize Corporation Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 168. Phillips-Medisize Corporation Recent Developments
  • Table 169. Sorrel Medical Company Information
  • Table 170. Sorrel Medical Description and Major Businesses
  • Table 171. Sorrel Medical Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 172. Sorrel Medical Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 173. Sorrel Medical Recent Developments
  • Table 174. Krontec Healthcare Company Information
  • Table 175. Krontec Healthcare Description and Major Businesses
  • Table 176. Krontec Healthcare Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 177. Krontec Healthcare Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 178. Krontec Healthcare Recent Developments
  • Table 179. Subcuject Aps Company Information
  • Table 180. Subcuject Aps Description and Major Businesses
  • Table 181. Subcuject Aps Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 182. Subcuject Aps Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 183. Subcuject Aps Recent Developments
  • Table 184. Ascendia Pharmaceuticals Company Information
  • Table 185. Ascendia Pharmaceuticals Description and Major Businesses
  • Table 186. Ascendia Pharmaceuticals Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 187. Ascendia Pharmaceuticals Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 188. Ascendia Pharmaceuticals Recent Developments
  • Table 189. West Pharmaceutical Services, Inc. Company Information
  • Table 190. West Pharmaceutical Services, Inc. Description and Major Businesses
  • Table 191. West Pharmaceutical Services, Inc. Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 192. West Pharmaceutical Services, Inc. Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 193. West Pharmaceutical Services, Inc. Recent Developments
  • Table 194. Key Raw Materials Lists
  • Table 195. Raw Materials Key Suppliers Lists
  • Table 196. Self-administered Parenteral Distributors List
  • Table 197. Self-administered Parenteral Customers List
  • Table 198. Self-administered Parenteral Market Trends
  • Table 199. Self-administered Parenteral Market Drivers
  • Table 200. Self-administered Parenteral Market Challenges
  • Table 201. Self-administered Parenteral Market Restraints
  • Table 202. Research Programs/Design for This Report
  • Table 203. Key Data Information from Secondary Sources
  • Table 204. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Self-administered Parenteral Product Picture
  • Figure 2. Global Self-administered Parenteral Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
  • Figure 3. Global Self-administered Parenteral Market Share by Type in 2023 & 2030
  • Figure 4. Pre-filled Syringes Product Picture
  • Figure 5. Autoinjectors Product Picture
  • Figure 6. Pen Injectors Product Picture
  • Figure 7. Others Product Picture
  • Figure 8. Global Self-administered Parenteral Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
  • Figure 9. Global Self-administered Parenteral Market Share by Application in 2023 & 2030
  • Figure 10. Pharmacy
  • Figure 11. Online Sales
  • Figure 12. Other
  • Figure 13. Self-administered Parenteral Report Years Considered
  • Figure 14. Global Self-administered Parenteral Revenue, (US$ Million), 2019 VS 2023 VS 2030
  • Figure 15. Global Self-administered Parenteral Revenue 2019-2030 (US$ Million)
  • Figure 16. Global Self-administered Parenteral Revenue Market Share by Region in Percentage: 2023 Versus 2030
  • Figure 17. Global Self-administered Parenteral Revenue Market Share by Region (2019-2030)
  • Figure 18. Global Self-administered Parenteral Sales 2019-2030 ((K Units)
  • Figure 19. Global Self-administered Parenteral Sales Market Share by Region (2019-2030)
  • Figure 20. US & Canada Self-administered Parenteral Sales YoY (2019-2030) & (K Units)
  • Figure 21. US & Canada Self-administered Parenteral Revenue YoY (2019-2030) & (US$ Million)
  • Figure 22. Europe Self-administered Parenteral Sales YoY (2019-2030) & (K Units)
  • Figure 23. Europe Self-administered Parenteral Revenue YoY (2019-2030) & (US$ Million)
  • Figure 24. China Self-administered Parenteral Sales YoY (2019-2030) & (K Units)
  • Figure 25. China Self-administered Parenteral Revenue YoY (2019-2030) & (US$ Million)
  • Figure 26. Asia (excluding China) Self-administered Parenteral Sales YoY (2019-2030) & (K Units)
  • Figure 27. Asia (excluding China) Self-administered Parenteral Revenue YoY (2019-2030) & (US$ Million)
  • Figure 28. Middle East, Africa and Latin America Self-administered Parenteral Sales YoY (2019-2030) & (K Units)
  • Figure 29. Middle East, Africa and Latin America Self-administered Parenteral Revenue YoY (2019-2030) & (US$ Million)
  • Figure 30. The Self-administered Parenteral Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
  • Figure 31. The Top 5 and 10 Largest Manufacturers of Self-administered Parenteral in the World: Market Share by Self-administered Parenteral Revenue in 2023
  • Figure 32. Global Self-administered Parenteral Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
  • Figure 33. Global Self-administered Parenteral Sales Market Share by Type (2019-2030)
  • Figure 34. Global Self-administered Parenteral Revenue Market Share by Type (2019-2030)
  • Figure 35. Global Self-administered Parenteral Sales Market Share by Application (2019-2030)
  • Figure 36. Global Self-administered Parenteral Revenue Market Share by Application (2019-2030)
  • Figure 37. US & Canada Self-administered Parenteral Sales Market Share by Type (2019-2030)
  • Figure 38. US & Canada Self-administered Parenteral Revenue Market Share by Type (2019-2030)
  • Figure 39. US & Canada Self-administered Parenteral Sales Market Share by Application (2019-2030)
  • Figure 40. US & Canada Self-administered Parenteral Revenue Market Share by Application (2019-2030)
  • Figure 41. US & Canada Self-administered Parenteral Revenue Share by Country (2019-2030)
  • Figure 42. US & Canada Self-administered Parenteral Sales Share by Country (2019-2030)
  • Figure 43. U.S. Self-administered Parenteral Revenue (2019-2030) & (US$ Million)
  • Figure 44. Canada Self-administered Parenteral Revenue (2019-2030) & (US$ Million)
  • Figure 45. Europe Self-administered Parenteral Sales Market Share by Type (2019-2030)
  • Figure 46. Europe Self-administered Parenteral Revenue Market Share by Type (2019-2030)
  • Figure 47. Europe Self-administered Parenteral Sales Market Share by Application (2019-2030)
  • Figure 48. Europe Self-administered Parenteral Revenue Market Share by Application (2019-2030)
  • Figure 49. Europe Self-administered Parenteral Revenue Share by Country (2019-2030)
  • Figure 50. Europe Self-administered Parenteral Sales Share by Country (2019-2030)
  • Figure 51. Germany Self-administered Parenteral Revenue (2019-2030) & (US$ Million)
  • Figure 52. France Self-administered Parenteral Revenue (2019-2030) & (US$ Million)
  • Figure 53. U.K. Self-administered Parenteral Revenue (2019-2030) & (US$ Million)
  • Figure 54. Italy Self-administered Parenteral Revenue (2019-2030) & (US$ Million)
  • Figure 55. Netherlands Self-administered Parenteral Revenue (2019-2030) & (US$ Million)
  • Figure 56. China Self-administered Parenteral Sales Market Share by Type (2019-2030)
  • Figure 57. China Self-administered Parenteral Revenue Market Share by Type (2019-2030)
  • Figure 58. China Self-administered Parenteral Sales Market Share by Application (2019-2030)
  • Figure 59. China Self-administered Parenteral Revenue Market Share by Application (2019-2030)
  • Figure 60. Asia Self-administered Parenteral Sales Market Share by Type (2019-2030)
  • Figure 61. Asia Self-administered Parenteral Revenue Market Share by Type (2019-2030)
  • Figure 62. Asia Self-administered Parenteral Sales Market Share by Application (2019-2030)
  • Figure 63. Asia Self-administered Parenteral Revenue Market Share by Application (2019-2030)
  • Figure 64. Asia Self-administered Parenteral Revenue Share by Region (2019-2030)
  • Figure 65. Asia Self-administered Parenteral Sales Share by Region (2019-2030)
  • Figure 66. Japan Self-administered Parenteral Revenue (2019-2030) & (US$ Million)
  • Figure 67. South Korea Self-administered Parenteral Revenue (2019-2030) & (US$ Million)
  • Figure 68. China Taiwan Self-administered Parenteral Revenue (2019-2030) & (US$ Million)
  • Figure 69. Southeast Asia Self-administered Parenteral Revenue (2019-2030) & (US$ Million)
  • Figure 70. India Self-administered Parenteral Revenue (2019-2030) & (US$ Million)
  • Figure 71. Middle East, Africa and Latin America Self-administered Parenteral Sales Market Share by Type (2019-2030)
  • Figure 72. Middle East, Africa and Latin America Self-administered Parenteral Revenue Market Share by Type (2019-2030)
  • Figure 73. Middle East, Africa and Latin America Self-administered Parenteral Sales Market Share by Application (2019-2030)
  • Figure 74. Middle East, Africa and Latin America Self-administered Parenteral Revenue Market Share by Application (2019-2030)
  • Figure 75. Middle East, Africa and Latin America Self-administered Parenteral Revenue Share by Country (2019-2030)
  • Figure 76. Middle East, Africa and Latin America Self-administered Parenteral Sales Share by Country (2019-2030)
  • Figure 77. Brazil Self-administered Parenteral Revenue (2019-2030) & (US$ Million)
  • Figure 78. Mexico Self-administered Parenteral Revenue (2019-2030) & (US$ Million)
  • Figure 79. Turkey Self-administered Parenteral Revenue (2019-2030) & (US$ Million)
  • Figure 80. Israel Self-administered Parenteral Revenue (2019-2030) & (US$ Million)
  • Figure 81. GCC Countries Self-administered Parenteral Revenue (2019-2030) & (US$ Million)
  • Figure 82. Self-administered Parenteral Value Chain
  • Figure 83. Self-administered Parenteral Production Process
  • Figure 84. Channels of Distribution
  • Figure 85. Distributors Profiles
  • Figure 86. Bottom-up and Top-down Approaches for This Report
  • Figure 87. Data Triangulation
  • Figure 88. Key Executives Interviewed
目次

This research report focuses on the Self-administered Parenteral Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Self-administered Parenteral Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Self-administered Parenteral Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
    • 1.2.2 Pre-filled Syringes
    • 1.2.3 Autoinjectors
    • 1.2.4 Pen Injectors
    • 1.2.5 Others
  • 1.3 Market by Application
    • 1.3.1 Global Self-administered Parenteral Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
    • 1.3.2 Pharmacy
    • 1.3.3 Online Sales
    • 1.3.4 Other
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Executive Summary

  • 2.1 Global Self-administered Parenteral Sales Estimates and Forecasts 2019-2030
  • 2.2 Global Self-administered Parenteral Revenue by Region
    • 2.2.1 Global Self-administered Parenteral Revenue by Region: 2019 VS 2023 VS 2030
    • 2.2.2 Global Self-administered Parenteral Revenue by Region (2019-2024)
    • 2.2.3 Global Self-administered Parenteral Revenue by Region (2025-2030)
    • 2.2.4 Global Self-administered Parenteral Revenue Market Share by Region (2019-2030)
  • 2.3 Global Self-administered Parenteral Sales Estimates and Forecasts 2019-2030
  • 2.4 Global Self-administered Parenteral Sales by Region
    • 2.4.1 Global Self-administered Parenteral Sales by Region: 2019 VS 2023 VS 2030
    • 2.4.2 Global Self-administered Parenteral Sales by Region (2019-2024)
    • 2.4.3 Global Self-administered Parenteral Sales by Region (2025-2030)
    • 2.4.4 Global Self-administered Parenteral Sales Market Share by Region (2019-2030)
  • 2.5 US & Canada
  • 2.6 Europe
  • 2.7 China
  • 2.8 Asia (excluding China)
  • 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

  • 3.1 Global Self-administered Parenteral Sales by Manufacturers
    • 3.1.1 Global Self-administered Parenteral Sales by Manufacturers (2019-2024)
    • 3.1.2 Global Self-administered Parenteral Sales Market Share by Manufacturers (2019-2024)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Self-administered Parenteral in 2023
  • 3.2 Global Self-administered Parenteral Revenue by Manufacturers
    • 3.2.1 Global Self-administered Parenteral Revenue by Manufacturers (2019-2024)
    • 3.2.2 Global Self-administered Parenteral Revenue Market Share by Manufacturers (2019-2024)
    • 3.2.3 Global Top 10 and Top 5 Companies by Self-administered Parenteral Revenue in 2023
  • 3.3 Global Key Players of Self-administered Parenteral, Industry Ranking, 2022 VS 2023 VS 2024
  • 3.4 Global Self-administered Parenteral Sales Price by Manufacturers
  • 3.5 Analysis of Competitive Landscape
    • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.5.2 Global Self-administered Parenteral Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.6 Global Key Manufacturers of Self-administered Parenteral, Manufacturing Base Distribution and Headquarters
  • 3.7 Global Key Manufacturers of Self-administered Parenteral, Product Offered and Application
  • 3.8 Global Key Manufacturers of Self-administered Parenteral, Date of Enter into This Industry
  • 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Self-administered Parenteral Sales by Type
    • 4.1.1 Global Self-administered Parenteral Historical Sales by Type (2019-2024)
    • 4.1.2 Global Self-administered Parenteral Forecasted Sales by Type (2025-2030)
    • 4.1.3 Global Self-administered Parenteral Sales Market Share by Type (2019-2030)
  • 4.2 Global Self-administered Parenteral Revenue by Type
    • 4.2.1 Global Self-administered Parenteral Historical Revenue by Type (2019-2024)
    • 4.2.2 Global Self-administered Parenteral Forecasted Revenue by Type (2025-2030)
    • 4.2.3 Global Self-administered Parenteral Revenue Market Share by Type (2019-2030)
  • 4.3 Global Self-administered Parenteral Price by Type
    • 4.3.1 Global Self-administered Parenteral Price by Type (2019-2024)
    • 4.3.2 Global Self-administered Parenteral Price Forecast by Type (2025-2030)

5 Market Size by Application

  • 5.1 Global Self-administered Parenteral Sales by Application
    • 5.1.1 Global Self-administered Parenteral Historical Sales by Application (2019-2024)
    • 5.1.2 Global Self-administered Parenteral Forecasted Sales by Application (2025-2030)
    • 5.1.3 Global Self-administered Parenteral Sales Market Share by Application (2019-2030)
  • 5.2 Global Self-administered Parenteral Revenue by Application
    • 5.2.1 Global Self-administered Parenteral Historical Revenue by Application (2019-2024)
    • 5.2.2 Global Self-administered Parenteral Forecasted Revenue by Application (2025-2030)
    • 5.2.3 Global Self-administered Parenteral Revenue Market Share by Application (2019-2030)
  • 5.3 Global Self-administered Parenteral Price by Application
    • 5.3.1 Global Self-administered Parenteral Price by Application (2019-2024)
    • 5.3.2 Global Self-administered Parenteral Price Forecast by Application (2025-2030)

6 US & Canada

  • 6.1 US & Canada Self-administered Parenteral Market Size by Type
    • 6.1.1 US & Canada Self-administered Parenteral Sales by Type (2019-2030)
    • 6.1.2 US & Canada Self-administered Parenteral Revenue by Type (2019-2030)
  • 6.2 US & Canada Self-administered Parenteral Market Size by Application
    • 6.2.1 US & Canada Self-administered Parenteral Sales by Application (2019-2030)
    • 6.2.2 US & Canada Self-administered Parenteral Revenue by Application (2019-2030)
  • 6.3 US & Canada Self-administered Parenteral Market Size by Country
    • 6.3.1 US & Canada Self-administered Parenteral Revenue by Country: 2019 VS 2023 VS 2030
    • 6.3.2 US & Canada Self-administered Parenteral Sales by Country (2019-2030)
    • 6.3.3 US & Canada Self-administered Parenteral Revenue by Country (2019-2030)
    • 6.3.4 US
    • 6.3.5 Canada

7 Europe

  • 7.1 Europe Self-administered Parenteral Market Size by Type
    • 7.1.1 Europe Self-administered Parenteral Sales by Type (2019-2030)
    • 7.1.2 Europe Self-administered Parenteral Revenue by Type (2019-2030)
  • 7.2 Europe Self-administered Parenteral Market Size by Application
    • 7.2.1 Europe Self-administered Parenteral Sales by Application (2019-2030)
    • 7.2.2 Europe Self-administered Parenteral Revenue by Application (2019-2030)
  • 7.3 Europe Self-administered Parenteral Market Size by Country
    • 7.3.1 Europe Self-administered Parenteral Revenue by Country: 2019 VS 2023 VS 2030
    • 7.3.2 Europe Self-administered Parenteral Sales by Country (2019-2030)
    • 7.3.3 Europe Self-administered Parenteral Revenue by Country (2019-2030)
    • 7.3.4 Germany
    • 7.3.5 France
    • 7.3.6 U.K.
    • 7.3.7 Italy
    • 7.3.8 Netherlands

8 China

  • 8.1 China Self-administered Parenteral Market Size
    • 8.1.1 China Self-administered Parenteral Sales (2019-2030)
    • 8.1.2 China Self-administered Parenteral Revenue (2019-2030)
  • 8.2 China Self-administered Parenteral Market Size by Application
    • 8.2.1 China Self-administered Parenteral Sales by Application (2019-2030)
    • 8.2.2 China Self-administered Parenteral Revenue by Application (2019-2030)

9 Asia (excluding China)

  • 9.1 Asia Self-administered Parenteral Market Size by Type
    • 9.1.1 Asia Self-administered Parenteral Sales by Type (2019-2030)
    • 9.1.2 Asia Self-administered Parenteral Revenue by Type (2019-2030)
  • 9.2 Asia Self-administered Parenteral Market Size by Application
    • 9.2.1 Asia Self-administered Parenteral Sales by Application (2019-2030)
    • 9.2.2 Asia Self-administered Parenteral Revenue by Application (2019-2030)
  • 9.3 Asia Self-administered Parenteral Sales by Region
    • 9.3.1 Asia Self-administered Parenteral Revenue by Region: 2019 VS 2023 VS 2030
    • 9.3.2 Asia Self-administered Parenteral Revenue by Region (2019-2030)
    • 9.3.3 Asia Self-administered Parenteral Sales by Region (2019-2030)
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 China Taiwan
    • 9.3.7 Southeast Asia
    • 9.3.8 India

10 Middle East, Africa and Latin America

  • 10.1 Middle East, Africa and Latin America Self-administered Parenteral Market Size by Type
    • 10.1.1 Middle East, Africa and Latin America Self-administered Parenteral Sales by Type (2019-2030)
    • 10.1.2 Middle East, Africa and Latin America Self-administered Parenteral Revenue by Type (2019-2030)
  • 10.2 Middle East, Africa and Latin America Self-administered Parenteral Market Size by Application
    • 10.2.1 Middle East, Africa and Latin America Self-administered Parenteral Sales by Application (2019-2030)
    • 10.2.2 Middle East, Africa and Latin America Self-administered Parenteral Revenue by Application (2019-2030)
  • 10.3 Middle East, Africa and Latin America Self-administered Parenteral Sales by Country
    • 10.3.1 Middle East, Africa and Latin America Self-administered Parenteral Revenue by Country: 2019 VS 2023 VS 2030
    • 10.3.2 Middle East, Africa and Latin America Self-administered Parenteral Revenue by Country (2019-2030)
    • 10.3.3 Middle East, Africa and Latin America Self-administered Parenteral Sales by Country (2019-2030)
    • 10.3.4 Brazil
    • 10.3.5 Mexico
    • 10.3.6 Turkey
    • 10.3.7 Israel
    • 10.3.8 GCC Countries

11 Company Profiles

  • 11.1 Becton, Dickinson and Company
    • 11.1.1 Becton, Dickinson and Company Company Information
    • 11.1.2 Becton, Dickinson and Company Overview
    • 11.1.3 Becton, Dickinson and Company Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.1.4 Becton, Dickinson and Company Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Becton, Dickinson and Company Recent Developments
  • 11.2 scPharmaceuticals
    • 11.2.1 scPharmaceuticals Company Information
    • 11.2.2 scPharmaceuticals Overview
    • 11.2.3 scPharmaceuticals Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.2.4 scPharmaceuticals Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 scPharmaceuticals Recent Developments
  • 11.3 Harro Hofliger
    • 11.3.1 Harro Hofliger Company Information
    • 11.3.2 Harro Hofliger Overview
    • 11.3.3 Harro Hofliger Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.3.4 Harro Hofliger Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Harro Hofliger Recent Developments
  • 11.4 Owen Mumford
    • 11.4.1 Owen Mumford Company Information
    • 11.4.2 Owen Mumford Overview
    • 11.4.3 Owen Mumford Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.4.4 Owen Mumford Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 Owen Mumford Recent Developments
  • 11.5 Haselmeier
    • 11.5.1 Haselmeier Company Information
    • 11.5.2 Haselmeier Overview
    • 11.5.3 Haselmeier Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.5.4 Haselmeier Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 Haselmeier Recent Developments
  • 11.6 Stevanato Group
    • 11.6.1 Stevanato Group Company Information
    • 11.6.2 Stevanato Group Overview
    • 11.6.3 Stevanato Group Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.6.4 Stevanato Group Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 Stevanato Group Recent Developments
  • 11.7 Ypsomed AG
    • 11.7.1 Ypsomed AG Company Information
    • 11.7.2 Ypsomed AG Overview
    • 11.7.3 Ypsomed AG Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.7.4 Ypsomed AG Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 Ypsomed AG Recent Developments
  • 11.8 Solteam Group
    • 11.8.1 Solteam Group Company Information
    • 11.8.2 Solteam Group Overview
    • 11.8.3 Solteam Group Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.8.4 Solteam Group Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 Solteam Group Recent Developments
  • 11.9 AstraZeneca
    • 11.9.1 AstraZeneca Company Information
    • 11.9.2 AstraZeneca Overview
    • 11.9.3 AstraZeneca Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.9.4 AstraZeneca Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 AstraZeneca Recent Developments
  • 11.10 Enable lnjections
    • 11.10.1 Enable lnjections Company Information
    • 11.10.2 Enable lnjections Overview
    • 11.10.3 Enable lnjections Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.10.4 Enable lnjections Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.10.5 Enable lnjections Recent Developments
  • 11.11 CCBio
    • 11.11.1 CCBio Company Information
    • 11.11.2 CCBio Overview
    • 11.11.3 CCBio Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.11.4 CCBio Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.11.5 CCBio Recent Developments
  • 11.12 Phillips-Medisize Corporation
    • 11.12.1 Phillips-Medisize Corporation Company Information
    • 11.12.2 Phillips-Medisize Corporation Overview
    • 11.12.3 Phillips-Medisize Corporation Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.12.4 Phillips-Medisize Corporation Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.12.5 Phillips-Medisize Corporation Recent Developments
  • 11.13 Sorrel Medical
    • 11.13.1 Sorrel Medical Company Information
    • 11.13.2 Sorrel Medical Overview
    • 11.13.3 Sorrel Medical Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.13.4 Sorrel Medical Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.13.5 Sorrel Medical Recent Developments
  • 11.14 Krontec Healthcare
    • 11.14.1 Krontec Healthcare Company Information
    • 11.14.2 Krontec Healthcare Overview
    • 11.14.3 Krontec Healthcare Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.14.4 Krontec Healthcare Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.14.5 Krontec Healthcare Recent Developments
  • 11.15 Subcuject Aps
    • 11.15.1 Subcuject Aps Company Information
    • 11.15.2 Subcuject Aps Overview
    • 11.15.3 Subcuject Aps Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.15.4 Subcuject Aps Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.15.5 Subcuject Aps Recent Developments
  • 11.16 Ascendia Pharmaceuticals
    • 11.16.1 Ascendia Pharmaceuticals Company Information
    • 11.16.2 Ascendia Pharmaceuticals Overview
    • 11.16.3 Ascendia Pharmaceuticals Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.16.4 Ascendia Pharmaceuticals Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.16.5 Ascendia Pharmaceuticals Recent Developments
  • 11.17 West Pharmaceutical Services, Inc.
    • 11.17.1 West Pharmaceutical Services, Inc. Company Information
    • 11.17.2 West Pharmaceutical Services, Inc. Overview
    • 11.17.3 West Pharmaceutical Services, Inc. Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.17.4 West Pharmaceutical Services, Inc. Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.17.5 West Pharmaceutical Services, Inc. Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Self-administered Parenteral Industry Chain Analysis
  • 12.2 Self-administered Parenteral Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Self-administered Parenteral Production Mode & Process
  • 12.4 Self-administered Parenteral Sales and Marketing
    • 12.4.1 Self-administered Parenteral Sales Channels
    • 12.4.2 Self-administered Parenteral Distributors
  • 12.5 Self-administered Parenteral Customers

13 Market Dynamics

  • 13.1 Self-administered Parenteral Industry Trends
  • 13.2 Self-administered Parenteral Market Drivers
  • 13.3 Self-administered Parenteral Market Challenges
  • 13.4 Self-administered Parenteral Market Restraints

14 Key Findings in The Global Self-administered Parenteral Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer